Igor D. Bandeira, MD, PhD
igorbandeira.bsky.social
Brazilian physician-scientist and aspiring psychiatrist. Postdoctoral Research Fellow at Stanford University. Brain Stimulation. Ketamine. Psychedelics. https://linktr.ee/igordbandeira
👤 Joined on 06 July 2023
927
Followers
191
Following
65
Total Posts
📜 Kullanıcı Geçmişi
- 06 Tem 2023, 01:09
🎉 Bluesky'e katıldı - İlk kullanıcı adı:
@igordbandeira.bsky.social - 13 Kas 2023, 02:05
🔄 Profil bilgileri güncellendi
- 04 Ara 2024, 08:01
✏️ Kullanıcı adı değişti:
@igordbandeira.bsky.social→@igorbandeira.bsky.social
🚫 Blokladığı Kullanıcılar
❤️ Beğendiği Gönderiler
Congratulations on this. This study is really promising for atypical suicidality. I hope this finding holds in future larger studies.
Show Post
Ketamine is fast, but fleeting. 🧪 Ep 65 explores a 2026 study showing low-dose buprenorphine *extends* ketamine's anti-suicidal effects! 🧠 Different brain circuits for depression & suicidal ideation? 💊 Buprenorphine acts like a "trellis" for fragile new connections. #Ketamine #Depression
Show PostLoved attending the Brazil Global Health Initiative event yesterday at Stanford. Always inspiring to connect with brilliant Brazilian researchers doing amazing work across Silicon Valley. Proud to be part of this community! 🇧🇷
Show Post
Congrats to all of the new @acnporg.bsky.social Members!!! #ACNP2026
Show Post
They suggest that future research should directly compare oral and depot naltrexone, systematically assess blinding, and account for comorbidities and sex differences to clarify ketamine’s mechanisms of action and guide clinical practice Check the paper for + info: doi.org/10.1093/ijnp...
Show Post